2023
DOI: 10.1136/flgastro-2023-102409
|View full text |Cite
|
Sign up to set email alerts
|

Establishing key performance indicators for inflammatory bowel disease in the UK

Abstract: Background and aimsHealthcare quality improvement (QI) is the systematic process to continuously improve the quality of care and outcomes for patients. The landmark Inflammatory Bowel Disease (IBD) UK National Audits provided a means to measure the variation in care, highlighting the need to define the standards of excellence in IBD care. Through a consensus approach, we aimed to establish key performance indicators (KPIs), providing reliable benchmarks for IBD care delivery in UK.MethodsKPIs that measure crit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…9 10 Moreover, time to diagnosis following referral has recently been established as a key performance indicator for IBD. 11 With burgeoning waiting lists for suspected IBD patients, effective triage of referrals from primary care is vital. A well-established tool to support this is faecal calprotectin (FCP) testing in primary care.…”
Section: What This Study Addsmentioning
confidence: 99%
“…9 10 Moreover, time to diagnosis following referral has recently been established as a key performance indicator for IBD. 11 With burgeoning waiting lists for suspected IBD patients, effective triage of referrals from primary care is vital. A well-established tool to support this is faecal calprotectin (FCP) testing in primary care.…”
Section: What This Study Addsmentioning
confidence: 99%
“…The British Society of Gastroenterology has recently published four IBD KPIs including 1) time from referral to diagnosis, 2) time from diagnosis to treatment, 3) steroid use, and 4) advanced therapy safety screening and efficacy assessments. (14) These will allow longitudinal assessments of services but require regular data collection for repeated audit cycles.…”
Section: Introductionmentioning
confidence: 99%